Strainprint is a demand-side cannabis data and analytics company, gathering cannabis consumption and efficacy data on lab-verified strains, while providing enterprise business intelligence to the global cannabis industry. Strainprint data supports global cannabis research and provides advanced business intelligence to producers, retailers, medical practitioners, pharma, government, and industry. Strainprint is military-grade encrypted and all patient data is anonymized and at rest.
Latest Strainprint News
Apr 26, 2023
About Aurora Aurora is opening the world to cannabis, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Aurora Drift , San Rafael '71 , Daily Special , Whistler , Being and Greybeard , as well as CBD brands, Reliva and KG7. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. as well as international brands, Pedanios, Bidiol and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd. , North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on Twitter and LinkedIn . Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Forward Looking Statements This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the launch of the Strainprint app and the associated benefits for patients of the Company. These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated September 20, 2022 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC's website at www.sec.gov . The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. View original content to download multimedia: https://www.prnewswire.com/news-releases/aurora-cannabis-partners-with-strainprint-to-empower-patients-on-their-cannabis-journey-301808361.html SOURCE Aurora Cannabis Inc.
Strainprint Frequently Asked Questions (FAQ)
Where is Strainprint's headquarters?
Strainprint's headquarters is located at Toronto.
What is Strainprint's latest funding round?
Strainprint's latest funding round is Series A.
How much did Strainprint raise?
Strainprint raised a total of $3M.
Who are the investors of Strainprint?
Investors of Strainprint include Core Strain and Cesare Fazari.
Who are Strainprint's competitors?
Competitors of Strainprint include Headset and 4 more.
Compare Strainprint to Competitors
Flourish is a software platform for cannabis cultivators, manufacturers, distributors, and retailers to track product from seed to sale, manage operations, and leverage advanced analytics.
Headset develops a cannabis business intelligence platform to serve cannabis retailers and producers. The platform assists in providing business insights and comparative reports on a broad install base of retail and dispensary integrations. The company was founded in 2015 and is based in Seattle, Washington.
LeafLink operates as a wholesale management platform for the cannabis industry. It supports participants in a business-to-business (B2B) supply chain. It provides basic tools designed to save money for retailers and allow producers to get good pricing for their products. The company was founded in 2016 and is based in New York, New York.
Genetica is an AI-powered cannabis retail platform. Its platform, Flora AI, analyzes data points to provide product recommendations, ensuring customers find the product in the cannabis and CBD industries. Its Flora Match leverages a combination of machine-learning science and consumer data, helping brands to caters to customer requirements and facilitate customer loyalty retention. It learns about a customer’s unique wants, needs, and health factors while curating a library of highly-cited, global cannabis research. The company was founded in 2020 and is based in Kansas City, Kansas.
s2solutions brings the cannabis industry out of the shadows and into the world of professional 21st Century business. The Washington-based company provides cannabis software solutions for client relationship management, automated order fulfillment, logistics, and business intelligence.
NatureTrak provides Risk Management & Compliance solutions to financial institutions that work with cannabis-related businesses (CRBs). Its enterprise tools provide the transparency and business intelligence needed by financial institutions to confidently serve their clients who operate marijuana, CBD, or hemp businesses. NatureTrak is integrated vertically throughout the CRB's supply chain, from inventory management, distribution, logistics, and digital transactions.